Manic episode in a patient with bipolar disorder after the use of peruvian maca: a case report
DOI:
https://doi.org/10.25118/2763-9037.2023.v13.430Keywords:
bipolar disorder, pseudocyesis, mania, peruvian macaAbstract
Abstract: Bipolar affective disorder (BPAD) is a complex group of chronic disorders that may, in its subcategory, course with bipolar I type, condition characterized by the presence of a manic episode associated with increased energy or activity and high, expansive or irritable mood, in addition to other signs and symptoms, and infrequently associated with pseudocyesis. The use of the herbal stimulant known as "peruvian maca" (derived from the tuber Lepidium meyenii) has effects on mood, affection and libido, and adverse effects and interactions with other medications may occur. This article presents the case report of a woman who underwent hospitalization in the psychiatry ward at Hospital das Clínicas da Faculdade de Medicina de Marília (HC FAMEMA), with a previous diagnosis of BPAD who had an episode of mania with clinical pseudocyesis after using the peruvian maca psychostimulant.
Downloads
Metrics
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington: American Psychiatric Association; 2013. https://doi.org/10.1176/appi.books.9780890425596
Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. Am J Psychiatry. 2020;177(8):706-15. https://doi.org/10.1176/appi.ajp.2020.19091000 - PMID:32312111 PMCID:PMC7577523
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet. 2020;396(10265):1841-56. https://doi.org/10.1016/S0140-6736(20)31544-0 PMID:33278937
Yutzy SH, Woofter CR, Abbott CC, Melhem IM, Parish BS. The increasing frequency of mania and bipolar disorder: causes and potential negative impacts. J Nerv Ment Dis. 2012;200(5):380-7. https://doi.org/10.1097/NMD.0b013e3182531f17 - PMID:22551790 - PMCID:PMC3632412
Kessing LV, González-Pinto A, Fagiolini A, Bechdolf A, Reif A, Yildiz A, Etain B, Henry C, Severus E, Reininghaus EZ, Morken G, Goodwin GM, Scott J, Geddes JR, Rietschel M, Landén M, Manchia M, Bauer M, Martinez-Cengotitabengoa M, Andreassen OA, Ritter P, Kupka R, Licht RW, Nielsen RE, Schulze TG, Hajek T, Lagerberg TV, Bergink V, Vieta E. DSM-5 and ICD-11 criteria for bipolar disorder: implications for the prevalence of bipolar disorder and validity of the diagnosis - a narrative review from the ECNP bipolar disorders network. Eur Neuropsychopharmacol. 2021;47:54-61. https://doi.org/10.1016/j.euroneuro.2021.01.097 - PMID:33541809
Espiridion ED, Fleckenstein C, Boyle P, Oladunjoye AO. A rare case of pseudocyesis in a patient with bipolar disorder. Cureus. 2020;12(9):e10352. https://doi.org/10.7759/cureus.10352 PMID:33062475 - PMCID:PMC7549847
Tsai CL, Shen YC. Delusion of triplet pregnancy in a manic patient. Prim Care Companion CNS Disord. 2016;18(1):10.4088/PCC.15l01833. https://doi.org/10.4088/PCC.15l01833 - PMID:27247836 PMCID:PMC4874756
Seeman MV. Pseudocyesis, delusional pregnancy, and psychosis: the birth of a delusion. World J Clin Cases. 2014;2(8):338-44. https://doi.org/10.12998/wjcc.v2.i8.338 - PMID:25133144 PMCID:PMC4133423
Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134-8. https://doi.org/10.1016/S0140-6736(99)06457-0 - PMID:10675182
Gonzales GF, Gonzales C, Gonzales-Castaneda C. Lepidium meyenii (maca): a plant from the highlands of Peru - from tradition to science. Forsch Komplementmed. 2009;16(6):373-80. https://doi.org/10.1159/000264618 - PMID:20090350
Peres NSL, Bortoluzzi LCP, Marques LLM, Formigoni M, Fuchs RHB, Droval AA, Cardoso FAR. Medicinal effects of peruvian maca (lepidium meyenii): a review. Food Funct. 2020;11(1):83-92. https://doi.org/10.1039/C9FO02732G - PMID:31951246
Beharry S, Heinrich M. Is the hype around the reproductive health claims of maca (lepidium meyenii walp.) justified? J Ethnopharmacol. 2018;211:126-70. https://doi.org/10.1016/j.jep.2017.08.003 - PMID:28811221
He Y, Sun Q, Zhang X, Bao X, Wang Y, Rasheed M, Guo B. Authentication of the geographical origin of maca (lepidium meyenii walp.) at different regional scales using the stable isotope ratio and mineral elemental fingerprints. Food Chem. 2020;311:126058. https://doi.org/10.1016/j.foodchem.2019.126058 - PMID:31869638
Bogani P, Simonini F, Iriti M, Rossoni M, Faoro F, Poletti A, Visioli F. Lepidium meyenii (maca) does not exert direct androgenic activities. J Ethnopharmacol. 2006;104(3):415-7. https://doi.org/10.1016/j.jep.2005.09.028 - PMID:16239088
Dording CM, Fisher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neurosci Ther. 2008;14(3):182-91. https://doi.org/10.1111/j.1755-5949.2008.00052.x - PMID:18801111 - PMCID:PMC6494062
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fellipe Oliveira Melo, Nadia Mori Vilares, Julia Leonelli Vono Antoniassi, Álvaro Tavares Figueiredo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
